Nuzenio

Moonlake Immunotherapeutics

Moonlake Immunotherapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Certain Stock Options of MoonLake Immunotherapeutics are subject to a Lock-Up Agreement Ending on 8-AUG-2026. - marketscreener.commarketscreener.com · Sat, 08 Aug 2026 00:22:39 GMTMLTX Stock Soars Overnight After FDA Backs Skin Drug Filing — Analyst Sees Over 300% Upside On ‘Best-In-Class’ Label - StocktwitsStocktwits · Fri, 07 Aug 2026 04:28:35 GMTRenaissance Technologies LLC Raises Stake in MoonLake Immunotherapeutics $MLTX - MarketBeatMarketBeat · Thu, 06 Aug 2026 08:47:34 GMTMoonLake Immunotherapeutics Insiders Sold US$8.7m Of Shares Suggesting Hesitancy - MoomooMoomoo · Wed, 05 Aug 2026 18:41:52 GMTMoonLake Immunotherapeutics (MLTX) Investor Outlook: Potential 60.92% Upside Sparks Interest - DirectorsTalk InterviewsDirectorsTalk Interviews · Tue, 04 Aug 2026 09:14:56 GMTInvestor Alert: Deadline Approaching to Join MoonLake Immunothera - The National Law ReviewThe National Law Review · Tue, 04 Aug 2026 06:56:09 GMTJanus Henderson Group PLC Increases Stock Position in MoonLake Immunotherapeutics $MLTX - MarketBeatMarketBeat · Sun, 02 Aug 2026 09:42:20 GMTWall Street Analysts See a 73.35% Upside in MOONLAKE IMMUNO (MLTX): Can the Stock Really Move This High? - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 00:22:39 GMTCertain Stock Options of MoonLake Immunotherapeutics are subject to a Lock-Up Agreement Ending on 8-AUG-2026. - marketscreener.com
Fri, 07 Aug 2026 04:28:35 GMTMLTX Stock Soars Overnight After FDA Backs Skin Drug Filing — Analyst Sees Over 300% Upside On ‘Best-In-Class’ Label - Stocktwits
Thu, 06 Aug 2026 08:47:34 GMTRenaissance Technologies LLC Raises Stake in MoonLake Immunotherapeutics $MLTX - MarketBeat
Wed, 05 Aug 2026 18:41:52 GMTMoonLake Immunotherapeutics Insiders Sold US$8.7m Of Shares Suggesting Hesitancy - Moomoo
Tue, 04 Aug 2026 09:14:56 GMTMoonLake Immunotherapeutics (MLTX) Investor Outlook: Potential 60.92% Upside Sparks Interest - DirectorsTalk Interviews
Tue, 04 Aug 2026 06:56:09 GMTInvestor Alert: Deadline Approaching to Join MoonLake Immunothera - The National Law Review

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Moonlake Immunotherapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.